Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 14.96M P/E - EPS this Y 52.30% Ern Qtrly Grth -
Income -26.92M Forward P/E -0.81 EPS next Y 87.40% 50D Avg Chg -5.00%
Sales 300.68k PEG - EPS past 5Y - 200D Avg Chg -19.00%
Dividend N/A Price/Book 0.65 EPS next 5Y - 52W High Chg -85.00%
Recommedations 2.00 Quick Ratio 0.29 Shares Outstanding 8.52M 52W Low Chg 7.00%
Insider Own 0.52% ROA -134.35% Shares Float 5.24M Beta 3.08
Inst Own 10.19% ROE -362.39% Shares Shorted/Prior 256.93K/623.33K Price 0.57
Gross Margin - Profit Margin - Avg. Volume 435,450 Target Price 42.00
Oper. Margin -1,683.61% Earnings Date Nov 6 Volume 149,309 Change 1.02%
About GeoVax Labs, Inc.

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; other infectious disease vaccines for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.

GeoVax Labs, Inc. News
11/19/24 GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia
11/13/24 Geovax Labs Inc (GOVX) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Challenges
11/12/24 GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update
11/12/24 GeoVax Labs initiated with a Buy at Alliance Global Partners
11/05/24 GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024
10/09/24 Geovax Labs Inc (GOVX) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...
10/02/24 GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
09/24/24 Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now
09/03/24 GeoVax Labs, Inc. (GOVX): A Hot Penny Stock On The Move
09/03/24 GeoVax to Participate in Upcoming Investor Conferences in September
08/28/24 GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market
08/27/24 Should You Buy GeoVax Labs Inc. (GOVX) After Golden Cross?
08:00 AM Registration is Now Open for Tribe Public’s Webinar Event "Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Lab’s CEO
08/20/24 GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market
08/20/24 Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now
08/19/24 WHO declares mpox a public health emergency as variant emerges
08/15/24 GeoVax to Present at the Emerging Growth Conference on August 21, 2024
08/08/24 GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board
08/06/24 GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update
07/31/24 Update: GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review
GOVX Chatroom

User Image lemon77 Posted - 14 minutes from now

$GOVX When will the results come out?

User Image tothemoon987 Posted - 7 minutes from now

$GOVX This is not moving anywhere, piece of shi** man

User Image Warren_8 Posted - 7 minutes from now

$GOVX WHO meeting tomorrow about MPOX, could blow if positive news for us

User Image sophrogeny Posted - 2 minutes from now

$GOVX Anyone attending the Society for Neuro-Oncology Annual Meeting in Houston please drop me a line.

User Image Manu56 Posted - 52 seconds from now

$GOVX boom💥💥💥🤣

User Image Manu56 Posted - 47 seconds ago

$GOVX 😎

User Image tothemoon987 Posted - 23 minutes ago

$GOVX This is a piece of sh**

User Image Beanie_Mojo Posted - 1 hour ago

$ITRM $GOVX $SOAR 👀. upon opening 🔔🔔🔔

User Image Warren_8 Posted - 5 hours ago

$GOVX could do with some huge positive news soon, need a big rise

User Image SumDay1Day Posted - 15 hours ago

$TNXP Could see today coming since AH yesterday. Now I'm back in again with a couple thousand shares. I love when I get back in stock that's all profits. Im not a short. But I'm also not an idiot. When you hit 50%+ in a few hours. I'm not sure what else to expect but a drop. We just played this game the other day with $GOVX. That's a hell of a PT though mates. Lets get it!

User Image tothemoon987 Posted - 19 hours ago

$GOVX WTF happened to the stock, analysts raising the target but no price action per ratings. Do you guys agree?

User Image Channelchek Posted - 19 hours ago

Noble Capital Markets Research Report: GeoVax Labs ($GOVX) – Interim Analysis Shows CM04S1 Outperforms mRNA Vaccines CM04S1 Continues In Phase 2 As DSMB Determines mRNA Vaccine Arm Failed Primary Endpoint. CM04S1 is in Phase 2 testing as a COVID-19 booster against an approved mRNA vaccine in patients with chronic lymphocytic leukemia (CLL). An interim analysis conducted by an independent Data Safety Monitoring and Review Board (DSMB) determined that the mRNA arm did not meet its specified primary endpoint, but the trial will continue with the CM04S1 arm. Read more: https://www.channelchek.com/news-channel/geovax-labs-govx-interim-analysis-shows-cm04s1-outperforms-mrna-vaccines #Investing #EquityResearch #Biotechnology #GeneTherapy #Immunotherapy #Vaccine

User Image luckysupernova Posted - 20 hours ago

$GOVX buy sub 2 again maybe.

User Image mendez628 Posted - 21 hours ago

$GOVX bro, wtf..

User Image captbaldric Posted - 21 hours ago

$GOVX I will buy at 1.8

User Image tothemoon987 Posted - 23 hours ago

$GOVX expecting this will hit 3.10 today, any takers?

User Image Warren_8 Posted - 23 hours ago

$GOVX f^cking hell. F^ck David A Dodd

User Image tothemoon987 Posted - 23 hours ago

$GOVX other vaccine stocks are up, but this is keep going down? Do you guys still think this will double this week?

User Image Raretype Posted - 23 hours ago

$GOVX I bought a measly 25 shares as a marker. Now it is on my position list. Out of sight, out of mind … so now I will see it. I am interested in this company.

User Image Trading_GM Posted - 23 hours ago

$GOVX When is the next reverse split?

User Image HiThereJakey Posted - 23 hours ago

$APDN picked these three stocks on the weekend, two have popped, $GOVX first and then $TNXP up like 80% at its peak. Just waiting on this one.

User Image gabbs Posted - 23 hours ago

$GOVX we'll have our $FBRX day... patience...

User Image sophrogeny Posted - 23 hours ago

@tothemoon987 were'nt you Bearish a few hours ago and bashing $GOVX?

User Image tothemoon987 Posted - 1 day ago

$GOVX what do you think this will hit $5? Is there a catalyst ?

User Image Warren_8 Posted - 1 day ago

$GOVX bounce back to green (I hope)

User Image mcrotary Posted - 1 day ago

$GOVX $5 or bust

User Image Manu56 Posted - 1 day ago

$GOVX yeah vote No No No !

User Image LHProxy Posted - 1 day ago

Special Shareholder Meeting has been adjourned again to December 18th! Every vote counts. Board recommends a vote FOR, but you can also cast an Against or Abstain Vote. To cast your vote, please call 844.303.2265.$GOVX

User Image Warren_8 Posted - 1 day ago

$GOVX bloody hell. Back to the usual shite

User Image AI_TRADER_ Posted - 1 day ago

$TVGN $ILLR $GOVX Will make you rich. $DJT

Analyst Ratings
Noble Capital Markets Outperform Aug 19, 24
EF Hutton Buy Aug 19, 24
HC Wainwright & Co. Buy Aug 12, 24
EF Hutton Buy Aug 7, 24
EF Hutton Buy Jul 23, 24
Roth MKM Buy Jul 16, 24
HC Wainwright & Co. Buy Jul 2, 24
HC Wainwright & Co. Buy Jun 18, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
McKee Kelly T. Jr. Chief Medical Office.. Chief Medical Officer Sep 25 Buy 0.52 9,653 5,020 28,838 09/27/23
Reynolds Mark CFO CFO Aug 18 Buy 0.5179 10,000 5,179 78,184 08/21/23
CHASE RANDAL D Director Director Sep 21 Buy 1.10 10,000 11,000 36,613 09/23/22
McKee Kelly T. Jr. Chief Medical Office.. Chief Medical Officer Jun 27 Buy 1.12 4,464 5,000 19,185 06/28/22
CHASE RANDAL D Director Director Jun 21 Buy 1.21 10,000 12,100 26,613 06/22/22
McKee Kelly T. Jr. Chief Medical Office.. Chief Medical Officer May 05 Buy 0.72 9,722 7,000 14,721 05/06/22